Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings

Authored by: Cozzi-Lepri Alessandro, Phillips Andrew N., Martinez-Picado Javier, Monforte Antonella d’Arminio, Katlama Christine, Eg Hansen Ann-Brit, Horban Andrzej, Bruun Johann, Clotet Bonaventura, Lundgren Jens D.
In: JOURNAL OF INFECTIOUS DISEASES 200(5), 2009, p.687-697